| pubmed-article:12894544 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12894544 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12894544 | lifeskim:mentions | umls-concept:C0007097 | lld:lifeskim |
| pubmed-article:12894544 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:12894544 | lifeskim:mentions | umls-concept:C0237284 | lld:lifeskim |
| pubmed-article:12894544 | lifeskim:mentions | umls-concept:C0009429 | lld:lifeskim |
| pubmed-article:12894544 | lifeskim:mentions | umls-concept:C0018270 | lld:lifeskim |
| pubmed-article:12894544 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:12894544 | lifeskim:mentions | umls-concept:C0556895 | lld:lifeskim |
| pubmed-article:12894544 | pubmed:issue | 3B | lld:pubmed |
| pubmed-article:12894544 | pubmed:dateCreated | 2003-8-4 | lld:pubmed |
| pubmed-article:12894544 | pubmed:abstractText | Previously we demonstrated that the antitumor efficacy of monoclonal antibodies against the EGFR (epidermal growth factor receptor) of human tumor xenografts mainly depends on the EGFR content of tumors rather than on the tumors' entity. In this study we wanted to elucidate whether the described cumulative effect of cisplatin and Anti-EGFR therapy also depends on the EGFR expression. | lld:pubmed |
| pubmed-article:12894544 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12894544 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12894544 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12894544 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12894544 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12894544 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12894544 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12894544 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12894544 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:12894544 | pubmed:author | pubmed-author:KnechtRR | lld:pubmed |
| pubmed-article:12894544 | pubmed:author | pubmed-author:PetersSS | lld:pubmed |
| pubmed-article:12894544 | pubmed:author | pubmed-author:StrebhardtKK | lld:pubmed |
| pubmed-article:12894544 | pubmed:author | pubmed-author:GstoettnerWW | lld:pubmed |
| pubmed-article:12894544 | pubmed:author | pubmed-author:AdunkaOO | lld:pubmed |
| pubmed-article:12894544 | pubmed:author | pubmed-author:HamberBB | lld:pubmed |
| pubmed-article:12894544 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12894544 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:12894544 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12894544 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12894544 | pubmed:pagination | 2577-83 | lld:pubmed |
| pubmed-article:12894544 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:meshHeading | pubmed-meshheading:12894544... | lld:pubmed |
| pubmed-article:12894544 | pubmed:articleTitle | Carcinomas unresponsive to either cisplatinum or anti-EGFR therapy can be growth inhibited by combination therapy of both agents. | lld:pubmed |
| pubmed-article:12894544 | pubmed:affiliation | Department of Otorhinolaryngology, University of Frankfurt, Medical School, 60590 Frankfurt/M., Germany. | lld:pubmed |
| pubmed-article:12894544 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12894544 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12894544 | lld:pubmed |
